Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Neutral

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Mereo BioPharma Group plc American Depositary Shares (MREO)

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a multi-asset, clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its oncology product candidate is etigilimab, for patients with solid tumors. Some of the other products in the pipeline are setrusumab, alvelestat, leflutrozole, navicixizumab, and acumapimod.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

04/24/2018

Market Cap

634,908,820

Shares Outstanding

701,220,000

Weighted SO

140,243,418

Total Employees

N/A

Upcoming Earnings

06/15/2020

Beta

0.8870

Last Div

0.0000

Range

1.07-4.5

Chg

0.1850

Avg Vol

1130140

Mkt Cap

634908820

Exch

NASDAQ

Country

GB

Phone

44 33 3023 7300

DCF Diff

4.2407

DCF

-0.0407

Div Yield

0.0000

P/S

709.7689

EV Multiple

-16.3112

P/FV

7.7195

Div Yield %

0.0000

P/E

-17.9489

PEG

-17.3720

Payout

0.0000

Current Ratio

6.0740

Quick Ratio

6.0740

Cash Ratio

5.6531

DSO

1090.6797

DIO

0.0004

Op Cycle

1090.6801

DPO

1068.9311

CCC

21.7490

Gross Margin

-0.0307

Op Margin

-38.6645

Pretax Margin

-37.6907

Net Margin

-37.8143

Eff Tax Rate

0.0109

ROA

-0.3519

ROE

-0.6339

ROCE

-0.4288

NI/EBT

1.0033

EBT/EBIT

0.9748

EBIT/Rev

-38.6645

Debt Ratio

0.0641

D/E

0.0783

LT Debt/Cap

0.0070

Total Debt/Cap

0.0727

Int Coverage

7.0842

CF/Debt

-3.3258

Equity Multi

1.2222

Rec Turnover

0.3347

Pay Turnover

0.3415

Inv Turnover

921949.0000

FA Turnover

0.6761

Asset Turnover

0.0093

OCF/Share

-0.1440

FCF/Share

-0.1460

Cash/Share

0.6142

OCF/Sales

-22.9101

FCF/OCF

1.0138

CF Coverage

-3.3258

ST Coverage

-3.6531

CapEx Coverage

-72.2531

Div&CapEx Cov

-72.2531

P/BV

7.7195

P/B

7.7195

P/S

709.7689

P/E

-17.9489

P/FCF

-30.5576

P/OCF

-29.6256

P/CF

-29.6256

PEG

-17.3720

P/S

709.7689

EV Multiple

-16.3112

P/FV

7.7195

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation